Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03337932 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Duration of Doxycycline Treatment in MEM Patients

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv9
  2. Primary and study completion dates: Dec 2024 to Dec 31, 2027v8
  3. Primary and study completion dates: Jan 2024 to Dec 2024
    • Start date: Jan 1, 2018 to May 1, 2018
    v7
  4. 3 versions Re-verified since Apr 19, 2019, no change to tracked fieldsv4-v6
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Dec 2017 to Jan 1, 2018
    v3
  6. Start date: Jan 2018 to Dec 2017v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare the efficacy of 7-day versus 14-day doxycycline treatment in patients with multiple erythema migrans.
Trial Details
NCT Number NCT03337932
Lead Sponsor University Medical Centre Ljubljana
Conditions
(from sponsor)		 Erythema Chronicum Migrans
Related terms Erythema Chronicum Migrans
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov